Company Ticker News January 12, 2022Biogen's stock tumbles after the U.S. proposes restricting access to its Alzheimer's disease drug 0 0 Share
Company Ticker News January 12, 2022CMS Proposes Coverage Of Biogen's Alzheimer's Drug, With Conditions Apply 0 0 Share
Company Ticker News January 12, 2022Biogen slumps after Medicare's restrictive decision on Alzheimer's drug 0 0 Share
Company Ticker News January 12, 2022Medicare limits coverage of Biogen's $28,000-a-year Alzheimer's drug 0 0 Share
Video News January 12, 2022Medicare will cover Biogen's $28K Alzheimer's drug, only in trials 0 0 Share
Company Ticker News January 11, 2022Medicare Seeks To Limit Coverage For Controversial Alzheimer's Drug Aduhelm 0 0 Share
